ADAR1 Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Sell
3,140
-6,500
-67% -$750K 0.02% 221
2025
Q4
$1.01M Sell
9,640
-8,900
-48% -$835K 0.07% 130
2025
Q3
$1.56M Buy
18,540
+11,500
+163% +$947K 0.15% 88
2025
Q2
$557K Buy
+7,040
New +$560K 0.09% 112
2025
Q1
Sell
-2,440
Closed -$243K 237
2024
Q4
$243K Buy
2,440
+1,300
+114% +$134K 0.05% 150
2024
Q3
$129K Sell
1,140
-74,610
-98% -$8.86M 0.02% 180
2024
Q2
$9.38M Buy
75,750
+75,450
+25,150% +$9.72M 1.77% 12
2024
Q1
$39.6K Sell
300
-53,700
-99% -$6.62M 0.01% 193
2023
Q4
$5.89M Buy
+54,000
New +$5.61M 2.1% 11

Other funds holding MRK

ADAR1 Capital Management's MRK Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Merck (MRK) stake by 67% in Q1 2026, selling an estimated $750K and leaving 3,140 shares worth $378K. The position accounts for 0.02% of the portfolio, ranked #221.

ADAR1 Capital Management first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $9.38M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • ADAR1 Capital Management held 3,140 shares of Merck worth $378K as of Q1 2026.
  • ADAR1 Capital Management sold 6,500 Merck shares in Q1 2026, an estimated $750K.
  • Merck made up 0.02% of ADAR1 Capital Management's portfolio in Q1 2026, its #221 holding.
  • ADAR1 Capital Management first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • ADAR1 Capital Management's Merck position peaked at $9.38M in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.